
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight Inc is positioned for sustained double-digit growth, driven by increased utilization of its Light Adjustable Lens (LAL) technology and a growing installed base of LDD systems. The company anticipates potential upside from factors such as faster growth in LDD installations, enhanced utilization rates, and improved margins as LALs represent a larger share of total revenue. Furthermore, RxSight expects improvements in cash burn, indicating operational efficiencies as the company's revenue mix evolves favorably.
Bears say
RxSight Inc. faces significant challenges that contribute to a negative financial outlook, primarily due to limited product adoption attributable to the necessity for additional capital equipment. The company has experienced disappointing commercial execution, compounded by increasing competition in the intraocular lens (IOL) market, which may hinder growth prospects. Furthermore, revised revenue projections indicate declines for both 2025 and 2026, with anticipated revenues adjusted down to $164 million and $205 million, respectively, suggesting more cautious market expectations.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares